This week, the Trump administration issued conflicting statements about the continuation of health insurance subsidies in the exchange markets, and released a limit set of fixes on Thursday. While the insurers agreed that the fixes to Obamacare are in the right direction, they continued to seek a guarantee on the continuation of subsidies. POTUS seemed to be in negotiation mode, refusing to confirm if he would continue the subsidies, in an apparent effort to force the Dems to the negotiating table.

IMT, the latest analysis by Standard and Poor reveals insurers will break even this year and some may even make profits. (I might add that all of this is moot if the Govt withdraws subsidies, in which case everyone loses).

7,000 rare diseases are affecting 25 million to 30 million Americans. However, the cost of treating these rare diseases is very high (thanks to the Orphan Drug Act of 1983 (ODA)). This is a big challenge for the US health care system. California, which failed to pass drug price control legislation last year, is mounting a new assault to regulate Pharma prices.

According to the latest study published by Health Affairs, most physicians are spending half their day on the EHR systems, which is unpaid work that the healthcare community has complained about for a long time.

Following a series of high-profile hacks, regulators and medical device makers are bracing for hacking attacks on medical devices like pacemakers and insulin pumps. It’s well known that medical devices have been the weakest link in the security chain.

You talkin’ to me? Amazon’s Alexa voice-enabled technologies could soon start helping diabetes patients. AWS and Merck have announced a developer competition to harness artificial intelligence for people with diabetes. Innovation gets crowdsourced.

Early to bed, early to rise. A new study suggests night owls should change their sleep patterns for better health.

Sign up for our newsletter The Healthcare Leader